|
Volumn 60, Issue 2, 2005, Pages
|
The Prescription Drug User Fee Act: Is a faster food and drug administration always a better Food and Drug Administration?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
DIETHYLENE GLYCOL;
NEW DRUG;
SULFANILAMIDE;
THALIDOMIDE;
BIRTH DEFECT;
CLINICAL RESEARCH;
DEATH;
DRUG APPROVAL;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GOOD MANUFACTURING PRACTICE;
GOVERNMENT;
HEALTH ECONOMICS;
HUMAN;
MEDICAL INFORMATION SYSTEM;
POSTMARKETING SURVEILLANCE;
PRESCRIPTION;
REVIEW;
RISK ASSESSMENT;
SIDE EFFECT;
UNITED STATES;
DRUG APPROVAL;
DRUG INDUSTRY;
FEES AND CHARGES;
HISTORY, 19TH CENTURY;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
LEGISLATION, DRUG;
PRESCRIPTIONS, DRUG;
PRODUCT SURVEILLANCE, POSTMARKETING;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 23444458067
PISSN: 1064590X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (30)
|
References (0)
|